An interventional study of exercise and limiting diet and diet limitation in Polycystic Ovary Syndrome, Dry Eye and Obesity, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to female participants aged 30 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-01-26.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 34 studies in Polycystic Ovary Syndrome by Cairo University — 10 open to participants now, 10 under way, none of them phase 3. Polycystic Ovary Syndrome · Cairo University.
Among the 34 studies in Polycystic Ovary Syndrome by Cairo University, this one is the 17th largest by planned enrollment of the 26 interventional ones that give a count, is one of 5 that started in 2025, is one of 20 with no phase, and was the 29th registered.
959 studies on the registry are indexed under Polycystic Ovary Syndrome; 176 are open to participants now.
Browse Polycystic Ovary Syndrome studies →10 of the 34 studies in Polycystic Ovary Syndrome by Cairo University are open now, in 1 country. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 20–40 · Women only
Cairo University · Sites in Egypt
Ages 20–30 · Women only
Cairo University · Sites in Egypt
Ages 35–45 · Women only
Cairo University · Sites in Egypt
Ages 18–35 · Women only
Cairo University · Sites in Egypt
Ages 20–35 · Women only
By country, each count listing its studies:
Of the 120 Polycystic Ovary Syndrome studies recruiting now, 11 (9%) set no upper age limit and 106 (88%) stop at 75 or younger; 23 take children under 18; 41 take healthy volunteers.
This study: 30 Years to 40 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
34 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 5 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 70 across 700 interventional studies indexed under Polycystic Ovary Syndrome.
Median enrollment 55 across the 26 interventional studies, 98 across the 8 observational. Of the 17 that completed or were terminated, 1 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
Cairo University is the lead sponsor of 4,967 studies on the registry; 1,474 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
3 of the studies in Polycystic Ovary Syndrome by Cairo University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07591246Cairo UniversityEfficay of Physical Activity Program in PCOS Females With Fatty Pancrease and Thyroid Hypofunction | 2026-12-30 |
| NCT07708766Cairo UniversityEffect of High Intensity Interval Training on Insulin Resistance in Polycystic Ovarian Syndrome | 2027-01-15 |
| NCT07937202Cairo UniversityEffects of Pilates Exercises on Doppler Parameters in Obese Females With Polycystic Ovarian Syndrome | 2027-04-15 |
Add all 3 to your calendar (.ics) → With an account.
Among the 34 studies in Polycystic Ovary Syndrome by Cairo University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Women with polycystic ovarian syndrome (PCOS) may complain dryness of their eyes especially obese ones. lifestye changes are main treatrment fro both problems
Forty females with PCOS, eye dryness , and obesity will asigned to group I or Group II, n=20 for each group. Both groups will receive metformin thrice times daily and low calorie diet for 12 weeks. Group I, additionally will perform one hour of treadmill walking thrice weekly for 12 weeks.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
twenty females with PCOS, eye dryness , and obesity will receive metformin thrice times daily and low calorie diet for 12 weeks. Group I, additionally will perform one hour of treadmill walking thrice weekly for 12 weeks.
Behavioral: exercise and limiting diet
Twenty females with PCOS, eye dryness , and obesity will receive metformin thrice times daily and low calorie diet for 12 weeks.
Behavioral: diet limitation
twenty females with PCOS, eye dryness , and obesity will receive metformin thrice times daily and low calorie diet for 12 weeks. Group I, additionally will perform one hour of treadmill walking thrice weekly for 12 weeks.
twenty females with PCOS, eye dryness , and obesity will receive metformin thrice times daily and low calorie diet for 12 weeks.
schrimer test
it is a test for assessment dye dryness
Time frame: it will be measured after 12 weeks
Ocular surface disability index
it is a questionaire for assessment dye dryness
Time frame: It will be measured after 12 weeks
dry eye scoring system
it is a questionaire for assessment dye dryness
Time frame: It will be measured after 12 weeks
Tear film break-up time
it is a test for assessment dye dryness
Time frame: It will be measured after 12 weeks
body mass index
it will be assessed on empty stomach and bowel
Time frame: it will be measured after 12 weeks
wasit hip ratio
it will be assessed by dividing wasit circuference on hip circumference
Time frame: It will be measured after 12 weeks
wasit circumference
it will be assessed by tape measure
Time frame: It will be measured after 12 weeks
testesterone
it will be assessed in serum
Time frame: It will be measured after 12 weeks
LH:FSH ratio
The LH (Luteinizing Hormone) to FSH (Follicle-Stimulating Hormone) ratio shows the balance between these reproductive hormones
Time frame: It will be measured after 12 weeks
dehydroepiandrosterone
it will ne assessed in serum
Time frame: It will be measured after 12 weeks
Started Dec 2025 (actual). Primary completion is estimated for Jun 2026, 6 months after the start.
Of 205 non-industry interventional studies with no phase under Polycystic Ovary Syndrome, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 37. This study's planned 6 months is below that.
Counting every sponsor, half of 220 studies reached it within 17 months; a quarter within 7 and three quarters within 37.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.